Literature DB >> 23417386

Spinal neurofibromatosis associated with classical neurofibromatosis type 1: genetic characterisation of an atypical case.

Kursat bora Carman1, Ayten Yakut, Banu Anlar, Sukriye Ayter.   

Abstract

Spinal tumours are observed in about 40% of neurofibromatosis type 1 (NF1) patients and occur within two subgroups: (1) NF1 patients carrying classical diagnostic criteria and only one or few spinal tumours and (2) patients with few NF1 stigmata but multiple bilateral spinal tumours, an entity called spinal neurofibromatosis. We report a young patient whose classical NF1 stigmata and numerous spinal neurofibromas matched both groups. He carried a single base deletion, c.389delA in exon 4a, which creates a premature termination at codon 164. This case illustrates the possibility of variant phenotypes and a novel NF1 mutation associated with spinal neurofibromatosis.

Entities:  

Mesh:

Year:  2013        PMID: 23417386      PMCID: PMC3604550          DOI: 10.1136/bcr-2012-008468

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  NF1 mutations and clinical spectrum in patients with spinal neurofibromas.

Authors:  L Kluwe; M Tatagiba; C Fünsterer; V-F Mautner
Journal:  J Med Genet       Date:  2003-05       Impact factor: 6.318

2.  A simple salting out procedure for extracting DNA from human nucleated cells.

Authors:  S A Miller; D D Dykes; H F Polesky
Journal:  Nucleic Acids Res       Date:  1988-02-11       Impact factor: 16.971

3.  Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference.

Authors: 
Journal:  Arch Neurol       Date:  1988-05

4.  Familial spinal neurofibromatosis due to a multiexonic NF1 gene deletion.

Authors:  Antonio Pizzuti; Irene Bottillo; Francesca Inzana; Valentina Lanari; Francesca Buttarelli; Isabella Torrente; Anna Teresa Giallonardo; Alessandro De Luca; Bruno Dallapiccola
Journal:  Neurogenetics       Date:  2011-03-02       Impact factor: 2.660

5.  Spinal tumours in neurofibromatosis type 1: an MRI study of frequency, multiplicity and variety.

Authors:  S D Thakkar; U Feigen; V F Mautner
Journal:  Neuroradiology       Date:  1999-09       Impact factor: 2.804

6.  Imatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trial.

Authors:  Kent A Robertson; Grzegorz Nalepa; Feng-Chun Yang; Daniel C Bowers; Chang Y Ho; Gary D Hutchins; James M Croop; Terry A Vik; Scott C Denne; Luis F Parada; Cynthia M Hingtgen; Laurence E Walsh; Menggang Yu; Kamnesh R Pradhan; Mary K Edwards-Brown; Mervyn D Cohen; James W Fletcher; Jeffrey B Travers; Karl W Staser; Melissa W Lee; Marcie R Sherman; Cynthia J Davis; Lucy C Miller; David A Ingram; D Wade Clapp
Journal:  Lancet Oncol       Date:  2012-10-23       Impact factor: 41.316

7.  A phase I trial and pharmacokinetic study of sorafenib in children with refractory solid tumors or leukemias: a Children's Oncology Group Phase I Consortium report.

Authors:  Brigitte C Widemann; Aerang Kim; Elizabeth Fox; Sylvain Baruchel; Peter C Adamson; Ashish M Ingle; Julia Glade Bender; Michael Burke; Brenda Weigel; Diana Stempak; Frank M Balis; Susan M Blaney
Journal:  Clin Cancer Res       Date:  2012-09-07       Impact factor: 12.531

8.  The spectrum of somatic and germline NF1 mutations in NF1 patients with spinal neurofibromas.

Authors:  Meena Upadhyaya; Gill Spurlock; Lan Kluwe; Nadia Chuzhanova; Emma Bennett; Nick Thomas; Abhijit Guha; Victor Mautner
Journal:  Neurogenetics       Date:  2009-02-17       Impact factor: 2.660

9.  A patient severely affected by spinal neurofibromas carries a recurrent splice site mutation in the NF1 gene.

Authors:  Katharina Wimmer; Manfred Mühlbauer; Markus Eckart; Tom Callens; Helga Rehder; Thomas Birkner; Jules G Leroy; Christa Fonatsch; Ludwine Messiaen
Journal:  Eur J Hum Genet       Date:  2002-05       Impact factor: 4.246

10.  Neurofibromatosis Type 1 and tumorigenesis: molecular mechanisms and therapeutic implications.

Authors:  Oren N Gottfried; David H Viskochil; William T Couldwell
Journal:  Neurosurg Focus       Date:  2010-01       Impact factor: 4.047

View more
  2 in total

Review 1.  Charcot-Marie-Tooth syndrome and neurofibromatosis type 1 with multiple neurofibromas of the entire spinal nerve roots.

Authors:  David O Onu; Andrew W Hunn; Jens Peters-Willke
Journal:  BMJ Case Rep       Date:  2013-07-13

2.  The gene diagnosis of neurofibromatosis type I with headache as the main symptom: A case report and review of the literature.

Authors:  Ming Gao; Haokun Liu; Qiying Sun; Guang Yang
Journal:  Front Neurol       Date:  2022-08-01       Impact factor: 4.086

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.